Platelet-activating factor (PAF): implications for coronary heart and vascular diseases.
Evangelou
A M
AM
Department of Exp. Physiology, Faculty of Medicine, University of Ioannina, Greece.
D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase; D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology; D001808:Blood Vessels / Q000187:drug effects; D003327:Coronary Disease / Q000209:etiology*; D016207:Cytokines / Q000502:physiology; D004730:Endothelium, Vascular / Q000502:physiology; D006801:Humans; D010741:Phospholipases A / Q000378:metabolism; D010972:Platelet Activating Factor / Q000494:pharmacology / Q000502:physiology*; D014652:Vascular Diseases / Q000209:etiology*; D014657:Vasculitis / Q000209:etiology
D016207:Cytokines; D010972:Platelet Activating Factor; D010741:Phospholipases A; D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase